Universal Ibogaine Cash Flow Statement

Financials in millions CAD. Fiscal year is August - July.

Millions CAD. Fiscal year is Aug - Jul.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY
Period Ending	Apr '25 Apr 30, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021	Mar '21 Mar 31, 2021
Net Income	-1.48	-2.05	-2.39	-10.5	-3.87	-0.29
Depreciation & Amortization	0.35	0.34	0.3	0.27	0.07	0
Stock-Based Compensation	-0.04	-0.02	0.1	0.9	-	0.02
Other Adjustments	0.66	1.12	0.4	5.5	0.83	-
Change in Receivables	-	-	-	-	-	-0.01
Changes in Accounts Payable	-	-	-	-	-	0.05
Changes in Other Operating Activities	-0.23	-0.23	0.5	-0.51	-0.28	0.09
Operating Cash Flow	-0.64	-0.84	-1.1	-4.33	-3.25	-0.21
Capital Expenditures	-0.02	-0.08	-0.36	-0.1	-	-
Sale of Property, Plant & Equipment	-	-	-	0.01	-	-
Payments for Business Acquisitions	-	-	-	-2.05	-	-
Other Investing Activities	-	-	-	0.04	-0.04	0.03
Investing Cash Flow	-0.02	-0.08	-0.36	-2.09	-0.04	0.03
Long-Term Debt Issued	-	-	1.11	1.63	0.39	0.06
Long-Term Debt Repaid	-0.11	-0.18	-0.06	-0.42	-0.1	-
Net Long-Term Debt Issued (Repaid)	-0.11	-0.18	1.05	1.21	0.29	0.06
Issuance of Common Stock	0.21	1.2	0.01	5.8	3.14	0.17
Net Common Stock Issued (Repurchased)	0.21	1.2	0.01	5.8	3.14	0.17
Other Financing Activities	0.38	-0.04	-0.01	-	-0.05	2.05
Financing Cash Flow	0.32	0.97	1.04	7.01	3.38	2.28
Net Cash Flow	-0.34	0.06	-0.41	0.58	0.09	2.1
Free Cash Flow	-0.66	-0.92	-1.46	-4.43	-3.25	-0.21
FCF Margin	-32.20%	-39.35%	-141.50%	-413.60%	-	-
Free Cash Flow Per Share	-0.00	-0.00	-0.01	-0.02	-0.03	-
Levered Free Cash Flow	-0.19	-1.32	-0.54	-9.63	-3.79	-0.09
Unlevered Free Cash Flow	0.68	0.01	-1.24	-3.42	-4.01	-0.15

Updated Apr 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.